跳至主要内容
临床试验/NCT07568470
NCT07568470Enrolling By Invitation不适用

Elicitation of the Phoenix Sign With Non-guided Subcutaneous D5W Infiltration

US Neuropathy Centers1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2026年4月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
600
试验地点
1

研究概览

简要总结

To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.

详细描述

  • To determine the prevalence of subclinical EHL weakness in a general clinical population
  • To measure the time course of strength changes following D5W infiltration
  • To identify potential predictive factors for positive response to treatment

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • subjects must have a weakness of dorsiflexion and specifically of the Extensor Hallucis Longus muscle
  • drop foot

排除标准

  • Trypanaphobia
  • allergy to D5W

研究组 & 干预措施

Infiltration of D5W

Experimental

3 cc's of D5W will be infiltrated subcutaneously at the level of the fibular neck to see if there is any improvement in dorsiflexion strength at 4 and 10 minutes post infiltration.

干预措施: Infiltration of D5W (Drug)

研究者

发起方
US Neuropathy Centers
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen Barrett

Principle Investigator

US Neuropathy Centers

研究点 (1)

Loading locations...

相似试验

Can the Phoenix Sign be Elicited With D5W | 临床试验